BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hong MZ, Ye L, Jin LX, Ren YD, Yu XF, Liu XB, Zhang RM, Fang K, Pan JS. Noninvasive scoring system for significant inflammation related to chronic hepatitis B. Sci Rep 2017;7:43752. [PMID: 28281521 DOI: 10.1038/srep43752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jia N, Gao W, Fan X, Gao H, Li X, Mi B, Yang J. Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study. Oxid Med Cell Longev 2022;2022:3185320. [PMID: 35726331 DOI: 10.1155/2022/3185320] [Reference Citation Analysis]
2 Liu J, Wang J, Yan X, Xue R, Zhan J, Jiang S, Geng Y, Liu Y, Mao M, Xia J, Yin S, Tong X, Chen Y, Ding W, Huang R, Wu C. Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis. Hepatol Commun 2021. [PMID: 34783181 DOI: 10.1002/hep4.1859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Zhang L, Li MH, Yi W, Lu Y, Wu S, Hao H, Gao Y, Lu H, Chen Q, Shen G, Chang M, Hu L, Liu R, Sun L, Wan G, Xie Y. AST and HBeAg Level Can Help to Distinguish Non-Minimal Liver Inflammation in Persistently Normal Alanine Aminotransferase of Chronic HBV Infection. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.99580] [Reference Citation Analysis]
4 Hsu TH, Tsui PH, Yu WT, Huang SF, Tai J, Wan YL, Tai DI. Cutoff Values of Acoustic Radiation Force Impulse Two-Location Measurements in Different Etiologies of Liver Fibrosis. J Med Ultrasound 2019;27:130-4. [PMID: 31867175 DOI: 10.4103/JMU.JMU_7_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zheng C, Yan H, Zeng J, Cai S, Wu X. Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B. Infect Drug Resist. 2019;12:845-854. [PMID: 31114265 DOI: 10.2147/idr.s195144] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
6 Yu XP, Wen X, Li J, Zheng YJ, Long JF, Zhao WD, Jiang PX, Wu JW, Zhu BD, Jiang QR, Yang FF, Shen ZL, Mao RC, Su ZJ, Zhang JM. A promising non-invasive index for predicting liver inflammation in chronic hepatitis B patients with alanine aminotransferase ≤2 upper limit of normal. Exp Ther Med 2018;16:4393-400. [PMID: 30542389 DOI: 10.3892/etm.2018.6751] [Reference Citation Analysis]